BioSpace News Archive

Business

Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies

Boehringer Ingelheim Expands Biomarker-driven Oncology Programs

November 15, 2018
·
3 min read
Biotech Bay

Anixa Biosciences To Present Cchek™ Breast Cancer Data at AACR Special Conference on Tumor Immunology and Immunotherapy

Anixa Biosciences, Inc. today announced that it will present data from its ongoing studies in breast cancer utilizing Cchek™, Anixa’s artificial intelligence (AI) driven early cancer detection technology, at the AACR Special Conference on Tumor Immunology and Immunotherapy.

November 15, 2018
·
4 min read
Genetown

Blueprint Medicines Announces Updated NAVIGATOR Trial Results in Patients with Advanced Gastrointestinal Stromal Tumors Supporting Development of Avapritinib Across All Lines of Therapy

84% ORR in PDGFRα D842V GIST and 20% ORR in fourth-line or later GIST support plans to submit New Drug Application to FDA in the first half of 2019

November 15, 2018
·
16 min read
Genetown

Lyndra Therapeutics Reports Positive Results from Pharmacokinetics (PK) Study of its Ultra-long-acting Oral Dosage Form

Study shows viability of taking once-weekly pill

November 15, 2018
·
3 min read
Business

GeneNews Announces Q3 2018 Results and Provides Progress Update

GeneNews Limited (TSX:GEN) (“GeneNews” or the “Company”) today announced operational and financial results for the three-month and nine-month periods ended September 30, 2018 and provided a progress update on its business.

November 15, 2018
·
4 min read
Drug Development

Visterra Presents Data Demonstrating Safety, Tolerability and Positive Clinical Activity Trends of VIS410 in Non-Hospitalized Patients with Influenza A

Visterra, Inc., a clinical stage biotechnology company, announced today that its Phase 2a study of VIS410, a novel monoclonal antibody, demonstrated safety, tolerability and clinical activity trends in non-hospitalized patients with influenza A.

November 15, 2018
·
5 min read
BioCapital

Peraton Awarded $243M Space Communications Network Services Contract Extension

Award reaffirms Peraton’s 30-year partnership supporting NASA missions

November 15, 2018
·
1 min read
Business

UCB and Verint Announce Launch of UCB’s PD Coach App, Powered by Verint’s Intelligent Virtual Assistant

Today, UCB, a global biopharmaceutical company working in Parkinson’s disease (PD) and other chronic illnesses, and Verint® Systems Inc. (Nasdaq: VRNT), The Customer Engagement Company™, announced the release of UCB’s PD Coach app

November 15, 2018
·
5 min read
Business

Beam Therapeutics Appoints Carole Ho, M.D., to Board of Directors

Dr. Ho brings to Beam more than 15 years of life sciences experience as a clinical neurologist, neuroscientist and leader in biopharmaceutical drug development.

November 15, 2018
·
2 min read
BioForest

FDA Grants Breakthrough Therapy Designation to ADCETRIS® (Brentuximab Vedotin) for Frontline Peripheral T-Cell Lymphomas

- Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to ADCETRIS

November 15, 2018
·
14 min read